Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Biotoxtech Co stock price, quote, forecast and news

086040.KQ
KR7086040003

Price

4,605.00
Today +/-
-0.18
Today %
-5.59 %
P

Biotoxtech Co stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Biotoxtech Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Biotoxtech Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Biotoxtech Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Biotoxtech Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Biotoxtech Co Stock Price History

DateBiotoxtech Co Price
9/4/20244,605.00 undefined
9/3/20244,870.00 undefined
9/2/20244,935.00 undefined
8/30/20244,955.00 undefined
8/29/20244,825.00 undefined
8/28/20244,980.00 undefined
8/27/20245,000.00 undefined
8/26/20244,940.00 undefined
8/23/20244,965.00 undefined
8/22/20244,980.00 undefined
8/21/20245,100.00 undefined
8/20/20245,120.00 undefined
8/19/20245,100.00 undefined
8/16/20244,955.00 undefined
8/14/20245,040.00 undefined
8/13/20244,955.00 undefined
8/12/20245,100.00 undefined
8/9/20244,915.00 undefined
8/8/20244,855.00 undefined

Biotoxtech Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Biotoxtech Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Biotoxtech Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Biotoxtech Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Biotoxtech Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Biotoxtech Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Biotoxtech Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Biotoxtech Co’s growth potential.

Biotoxtech Co Revenue, EBIT and net profit per share

DateBiotoxtech Co RevenueBiotoxtech Co EBITBiotoxtech Co Net Income
202332.63 B undefined-8.19 B undefined-4.88 B undefined
202237.29 B undefined800.05 M undefined2.73 B undefined
202132.72 B undefined4.63 B undefined7.11 B undefined
202026.43 B undefined537 M undefined2.61 B undefined
201925.85 B undefined-131 M undefined-1.58 B undefined
201827.25 B undefined2.28 B undefined3.62 B undefined
201725.57 B undefined2.19 B undefined1.39 B undefined
201622.26 B undefined2.2 B undefined1.04 B undefined
201516.68 B undefined-3.7 B undefined-3.9 B undefined
201415.09 B undefined-4.65 B undefined-4.53 B undefined
201317.27 B undefined-1.83 B undefined-83 M undefined
201217.72 B undefined255 M undefined1.35 B undefined
201123.09 B undefined5.09 B undefined3.27 B undefined
201018.73 B undefined2.77 B undefined354 M undefined
200916.26 B undefined3.04 B undefined4.14 B undefined
200810.03 B undefined-613 M undefined-9.14 B undefined
200710.04 B undefined1.02 B undefined197 M undefined
20069.01 B undefined821 M undefined249 M undefined
20057.51 B undefined372 M undefined239 M undefined
20045.08 B undefined-574 M undefined-945 M undefined

Biotoxtech Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
2.852.85.087.519.0110.0410.0316.2618.7323.0917.7217.2715.0916.6822.2625.5727.2525.8526.4332.7237.2932.63
--1.5181.1647.9319.9511.44-0.0562.1015.2023.24-23.27-2.51-12.6410.5233.4714.866.57-5.112.2223.7913.98-12.50
27.70-3.0316.4530.2331.0830.4621.3033.9331.7339.8425.1619.2111.3718.2833.1335.6828.1620.7724.3532.2333.465.82
0.79-0.090.842.272.83.062.145.525.949.24.463.321.723.057.379.127.675.376.4410.5512.481.9
-0.36-1.48-0.570.370.821.02-0.613.042.775.090.26-1.83-4.65-3.72.22.192.28-0.130.544.630.8-8.19
-12.55-52.75-11.314.959.1210.18-6.1118.6814.7922.051.44-10.60-30.80-22.199.898.558.35-0.512.0314.152.15-25.09
-0.64-1.6-0.950.240.250.2-9.144.140.353.271.35-0.08-4.53-3.91.041.393.62-1.582.617.112.73-4.88
-149.22-40.94-125.294.18-20.88-4,737.06-145.33-91.45824.86-58.74-106.145,353.01-13.74-126.7433.33160.34-143.65-265.23172.15-61.70-278.97
33333899101012121114141415151515.3914.6415.43
----------------------
Details

Keystats

ⓘ

Revenue and Growth

The Biotoxtech Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Biotoxtech Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (B)INVENTORIES (B)OTHER CURRENT LIAB. (B)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (B)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (B)UNREAL. GAINS/LOSSES (B)EQUITY (B)LIABILITIES (B)PROVISIONS (M)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (B)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (B)OTHER LIAB. (B)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                           
0.081.680.123.353.15.852.277.8711.627.787.739.9713.178.8611.867.210.319.3820.6127.5928.2131.48
0.70.441.381.311.33.292.362.323.795.915.875.343.823.833.243.463.214.773.825.917.495.78
0.0600.0100.310.010.151.120.040.040.290.150.230.060.340.570.551.361.152.732.772.9
0.040.020.160.250.190.370.260.370.790.470.580.80.60.660.860.940.970.710.840.674.4511.92
0.010.040.020.340.420.770.430.260.260.10.10.180.020.130.030.990.830.960.750.856.212.62
0.892.181.695.255.3110.295.4711.9416.5114.314.5616.4417.8413.5516.3313.1615.8617.1827.1837.7549.1364.69
7.877.356.986.6713.2715.3123.8722.5121.5322.8523.322.5721.5520.8120.0822.3223.0621.9722.0625.4158.0758.18
000000.640.470.380.881.260.872.333.195.987.348.513.3618.7111.1218.3710.1310.69
00000000000000000.380.841.316.2354.67
0000.010.040.471.221.393.493.663.83.623.182.171.768.125.80.221.321.541.481.6
0000000000000005.444.2800000
0.10.140.110.41.021.071.371.922.432.132.151.332.072.872.492.230.391.250.681.451.897.21
7.977.487.097.0814.3317.4926.9326.1928.3229.930.1229.863031.8331.6746.6147.274336.4852.9976.5782.34
8.869.668.7812.3319.6527.7832.438.1344.8444.244.6846.2947.8445.3848.0159.7763.1460.1863.6690.74125.7147.04
                                           
0.611.61.622.433.123.963.964.434.434.815.615.617.217.217.217.257.287.297.317.337.337.98
1.432.022.095.317.8912.6212.6214.398.479.5813.3813.3818.5318.5318.6319.0119.4419.6319.9721.0621.634.12
-0.39-2.42-3.59-2.94-1.65-1.5-10.64-6.50.063.264.424.16-0.77-4.59-3.49-2.061.760.092.439.3512.166.74
0000000000000.160.40.170.190.511.181.471.321.261.33
000000.022.012.012.012.311.951.851.822.112.192.372.432.172.512.252.041.7
1.651.20.134.89.3615.17.9614.3314.9719.9725.362526.9623.6724.7126.7631.4230.3633.6941.3144.451.88
0.050.160.540.330.290.420.560.630.530.560.560.50.530.550.741.321.020.740.820.820.780.54
8228271817213723849238492280220220675310666578652502.65255.57576.28
0.551.070.831.031.190.91.582.355.2144.253.62.764.264.986.466.919.379.9119.4229.4932.6
000.150.6803.25.274.67.619.059.0411.1712.1614.1113.4914.715.2610.689.4113.3414.3523.83
0.411.440.611.170.531.350.946.247.973.492.520.572.500000.824.9311.714.6517.57
1.092.692.163.222.035.898.3914.0721.817.4816.4516.1318.1719.1419.8922.7923.8722.1825.7245.7859.5375.12
6.025.566.064.087.86.4215.469.126.813.750.632.50000.61.55.942.932.0120.1420.19
0000000000000001.470.5900000
0.10.210.440.240.450.380.580.621.261.221.672.062.982.662.563.671.430.860.731.111.673.49
6.125.776.54.318.256.816.059.748.074.972.314.562.982.662.565.743.526.83.663.1121.8123.68
7.218.468.657.5310.2812.6924.4423.8129.8722.4518.7520.6921.1521.822.4528.5327.3928.9829.3748.8981.3398.8
8.869.668.7812.3319.6527.7832.438.1444.8442.4344.1245.748.1145.4647.1555.2958.8159.3463.0790.2125.73150.68
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Biotoxtech Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Biotoxtech Co's financial health and stability.

Assets

Biotoxtech Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Biotoxtech Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Biotoxtech Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Biotoxtech Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (B)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (B)NON-CASH ITEM (B)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (B)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
200220032004200520062007200820092010201120122013201420152016201720182019202020212022
-0.64-2.03-1.160.651.290.15-9.134.140.353.081.15-0.56-4.89-3.711.161.183.49-1.712.376.981.51
0.390.70.790.820.791.151.662.021.951.871.661.871.771.651.521.92.842.071.631.671.94
-37053-532-12572-603-3270000000000000
-0.20.75-0.82-1.01-0.27-3.010.580.580.21-3.98-1.42-1.56-1.22-1.61-0.150.77-2.72-1.321.41-3.08-8.23
0.210.210.470.72-0.121.29.21-0.983.662.310.250.032.32.872.752.18-0.552.4-0.84-1.233.47
00000000744659547446529504497482595570448413835
0000000034-8-5-17-1143-8895243014214
-0.28-0.38-0.680.641.57-0.441.715.436.183.281.63-0.22-2.05-0.85.286.023.061.444.564.35-1.31
-5,051-181-431-516-7,426-3,620-8,338-829-3,092-3,366-2,878-986-305-496-491-3,413-2,330-487-2,540-7,956-30,785
-5.09-1.711.05-3.14-6.3-7.83-5.62-5.9-3.41-1.92-2.37-0.34-4.34-0.62-0.39-11.51-5.74-2.87-7.01-7.76-26.4
-0.04-1.531.48-2.621.13-4.212.72-5.07-0.311.450.510.64-4.04-0.130.11-8.1-3.41-2.38-4.470.24.39
000000000000000000000
4.790.65-0.54-0.854.162.823.650.230.32-7.26-2.233.30.55-0.61-0.691.91.40.2-0.3819.0721.93
01.540.141.875.0202.0303.463.606.7500.540.30.330.150.250.390
4.792.2-0.443.146.027.473.932.280.39-2.921.453.36.33-0.61-0.232.171.740.57-0.1419.2821.93
000-8-5-365277247287579-4-9592-77-344210-11-180-5
000000000000000000000
-0.580.11-0.070.641.3-0.790.021.823.16-1.560.572.63-0.08-1.934.73-3.51-0.89-0.84-2.6315.84-5.89
-5,328.5-556.9-1,108.4119.3-5,859.6-4,057.9-6,6304,604.93,086.5-86.7-1,247.1-1,203.7-2,353.1-1,294.64,791.82,610.7731.2956.22,023.5-3,610.16-32,094.43
000000000000000000000

Biotoxtech Co stock margins

The Biotoxtech Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Biotoxtech Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Biotoxtech Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Biotoxtech Co's sales revenue. A higher gross margin percentage indicates that the Biotoxtech Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Biotoxtech Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Biotoxtech Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Biotoxtech Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Biotoxtech Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Biotoxtech Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Biotoxtech Co Margin History

Biotoxtech Co Gross marginBiotoxtech Co Profit marginBiotoxtech Co EBIT marginBiotoxtech Co Profit margin
20235.82 %-25.09 %-14.95 %
202233.47 %2.15 %7.31 %
202132.23 %14.16 %21.74 %
202024.35 %2.03 %9.89 %
201920.77 %-0.51 %-6.12 %
201828.16 %8.35 %13.3 %
201735.68 %8.55 %5.44 %
201633.13 %9.89 %4.69 %
201518.28 %-22.19 %-23.41 %
201411.37 %-30.8 %-30 %
201319.21 %-10.6 %-0.48 %
201225.16 %1.44 %7.63 %
201139.84 %22.05 %14.18 %
201031.73 %14.79 %1.89 %
200933.93 %18.68 %25.46 %
200821.3 %-6.11 %-91.06 %
200730.46 %10.18 %1.96 %
200631.08 %9.12 %2.76 %
200530.23 %4.95 %3.18 %
200416.45 %-11.31 %-18.62 %

Biotoxtech Co Stock Sales Revenue, EBIT, Earnings per Share

The Biotoxtech Co earnings per share therefore indicates how much revenue Biotoxtech Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Biotoxtech Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Biotoxtech Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Biotoxtech Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Biotoxtech Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Biotoxtech Co Revenue, EBIT and net profit per share

DateBiotoxtech Co Sales per ShareBiotoxtech Co EBIT per shareBiotoxtech Co Earnings per Share
20232,114.92 undefined-530.63 undefined-316.14 undefined
20222,547.88 undefined54.66 undefined186.19 undefined
20212,125.68 undefined300.93 undefined462.21 undefined
20201,761.93 undefined35.8 undefined174.27 undefined
20191,723.6 undefined-8.73 undefined-105.47 undefined
20181,816.33 undefined151.73 undefined241.6 undefined
20171,826.07 undefined156.14 undefined99.43 undefined
20161,589.79 undefined157.29 undefined74.57 undefined
20151,191.14 undefined-264.29 undefined-278.86 undefined
20141,371.64 undefined-422.45 undefined-411.45 undefined
20131,439.33 undefined-152.58 undefined-6.92 undefined
20121,476.33 undefined21.25 undefined112.58 undefined
20112,308.8 undefined509.2 undefined327.4 undefined
20101,873.4 undefined277 undefined35.4 undefined
20091,806.89 undefined337.56 undefined460.11 undefined
20081,114.67 undefined-68.11 undefined-1,015 undefined
20071,254.63 undefined127.75 undefined24.63 undefined
20063,002.33 undefined273.67 undefined83 undefined
20052,503 undefined124 undefined79.67 undefined
20041,692 undefined-191.33 undefined-315 undefined

Biotoxtech Co business model

Biotoxtech Co is one of the most popular companies on Eulerpool.com.

Biotoxtech Co Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Biotoxtech Co historical P/E ratio, EBIT, and P/S ratio.

Biotoxtech Co shares outstanding

The number of shares was Biotoxtech Co in 2023 — This indicates how many shares 15.429 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Biotoxtech Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Biotoxtech Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Biotoxtech Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Biotoxtech Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Biotoxtech Co.

Biotoxtech Co latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/201821.99 143  (550.18 %)2018 Q3
6/30/201851.28 -29  (-156.56 %)2018 Q2
3/31/201821.93 264  (1,103.93 %)2018 Q1
1

Biotoxtech Co list of shareholders

%
Name
Stocks
Change
Date
7.57 % Cypron Bio Co., Ltd.1,206,15909/30/2023
12.78 % Gang (Jong Gu)2,035,96509/30/2023
10.24 % Celltrion Inc1,631,13409/30/2023
0.99 % Yun (Seok Cheon)158,00009/30/2023
0.40 % Dimensional Fund Advisors, L.P.62,98901/31/2024
0.32 % Gang (Gyeong Ae)51,59909/30/2023
0.16 % Lee (Myeong Jeong)25,00009/30/2023
0.10 % Kim (Dong Il)16,12809/30/2023
0.09 % Gang (Seok Mo)14,35109/30/2023
0.08 % Gang (Il Mo)12,57309/30/2023
1
2

Most common questions regarding Biotoxtech Co

What is the P/E ratio of Biotoxtech Co 2024?

The P/E ratio cannot be calculated for Biotoxtech Co at the moment.

What is the P/S ratio of Biotoxtech Co 2024?

The P/S cannot be calculated for Biotoxtech Co currently.

What is the AlleAktien quality score of Biotoxtech Co?

The AlleAktien quality score for Biotoxtech Co is 4/10.

What is the revenue of Biotoxtech Co 2024?

The revenue cannot currently be calculated for Biotoxtech Co.

How high is the profit of Biotoxtech Co 2024?

The profit cannot currently be calculated for Biotoxtech Co.

What is the business model of Biotoxtech Co

No history available for Biotoxtech Co.

What is the Biotoxtech Co dividend?

Biotoxtech Co pays a dividend of 0 KRW distributed over payouts per year.

How often does Biotoxtech Co pay dividends?

The dividend cannot currently be calculated for Biotoxtech Co or the company does not pay out a dividend.

What is the Biotoxtech Co ISIN?

The ISIN of Biotoxtech Co is KR7086040003.

What is the Biotoxtech Co ticker?

The ticker of Biotoxtech Co is 086040.KQ.

How much dividend does Biotoxtech Co pay?

Over the past 12 months, Biotoxtech Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biotoxtech Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of Biotoxtech Co?

The current dividend yield of Biotoxtech Co is .

When does Biotoxtech Co pay dividends?

Biotoxtech Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Biotoxtech Co?

Biotoxtech Co paid dividends every year for the past 0 years.

What is the dividend of Biotoxtech Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is Biotoxtech Co located?

Biotoxtech Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Biotoxtech Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Biotoxtech Co from 9/6/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 9/6/2024.

When did Biotoxtech Co pay the last dividend?

The last dividend was paid out on 9/6/2024.

What was the dividend of Biotoxtech Co in the year 2023?

In the year 2023, Biotoxtech Co distributed 0 KRW as dividends.

In which currency does Biotoxtech Co pay out the dividend?

The dividends of Biotoxtech Co are distributed in KRW.

All fundamentals about Biotoxtech Co

Our stock analysis for Biotoxtech Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biotoxtech Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.